Hemant Roy to Risk Assessment
This is a "connection" page, showing publications Hemant Roy has written about Risk Assessment.
Connection Strength
0.237
-
Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study. PLoS One. 2018; 13(5):e0197427.
Score: 0.091
-
Nanocytology for field carcinogenesis detection: novel paradigm for lung cancer risk stratification. Future Oncol. 2011 Jan; 7(1):1-3.
Score: 0.054
-
Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: Influence of smoking. World J Gastroenterol. 2006 Jul 28; 12(28):4485-91.
Score: 0.040
-
ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. Trials. 2017 02 01; 18(1):50.
Score: 0.021
-
In vivo risk analysis of pancreatic cancer through optical characterization of duodenal mucosa. Pancreas. 2015 Jul; 44(5):735-41.
Score: 0.019
-
Association of colorectal cancer and prostate cancer and impact of radiation therapy. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):1979-85.
Score: 0.012